These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 36627174)

  • 1. Presentation of Graves' orbitopathy within European Group On Graves' Orbitopathy (EUGOGO) centres from 2012 to 2019 (PREGO III).
    Schuh A; Ayvaz G; Baldeschi L; Baretić M; Bechtold D; Boschi A; Brix TH; Burlacu MC; Ciric J; Covelli D; Currò N; Donati S; Eckstein AK; Fichter N; Führer D; Horn M; Jabłońska-Pawlak A; Juri Mandić J; Kahaly GJ; Konuk O; Langbein A; Lanzolla G; Marcocci C; Marinò M; Miśkiewicz P; Beleslin BN; Pérez-Lázaro A; Pérez-López M; Ponto KA; Quinn A; Rudofsky G; Salvi M; Schittkowski MP; Tanda ML; Toruner F; Vaidya B; Hintschich CR
    Br J Ophthalmol; 2024 Jan; 108(2):294-300. PubMed ID: 36627174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PREGO (presentation of Graves' orbitopathy) study: changes in referral patterns to European Group On Graves' Orbitopathy (EUGOGO) centres over the period from 2000 to 2012.
    Perros P; Žarković M; Azzolini C; Ayvaz G; Baldeschi L; Bartalena L; Boschi A; Bournaud C; Brix TH; Covelli D; Ćirić S; Daumerie C; Eckstein A; Fichter N; Führer D; Hegedüs L; Kahaly GJ; Konuk O; Lareida J; Lazarus J; Leo M; Mathiopoulou L; Menconi F; Morris D; Okosieme O; Orgiazzi J; Pitz S; Salvi M; Vardanian-Vartin C; Wiersinga W; Bernard M; Clarke L; Currò N; Dayan C; Dickinson J; Knežević M; Lane C; Marcocci C; Marinò M; Möller L; Nardi M; Neoh C; Pearce S; von Arx G; Törüner FB
    Br J Ophthalmol; 2015 Nov; 99(11):1531-5. PubMed ID: 25953846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Asymmetry indicates more severe and active disease in Graves' orbitopathy: results from a prospective cross-sectional multicentre study.
    Perros P; Žarković MP; Panagiotou GC; Azzolini C; Ayvaz G; Baldeschi L; Bartalena L; Boschi AM; Nardi M; Brix TH; Covelli D; Daumerie C; Eckstein AK; Fichter N; Ćirić S; Hegedüs L; Kahaly GJ; Konuk O; Lareida JJ; Okosieme OE; Leo M; Mathiopoulou L; Clarke L; Menconi F; Morris DS; Orgiazzi J; Pitz S; Salvi M; Muller I; Knežević M; Wiersinga WM; Currò N; Dayan CM; Marcocci C; Marinò M; Möller L; Pearce SH; Törüner F; Bernard M;
    J Endocrinol Invest; 2020 Dec; 43(12):1717-1722. PubMed ID: 32474767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The 2021 European Group on Graves' orbitopathy (EUGOGO) clinical practice guidelines for the medical management of Graves' orbitopathy.
    Bartalena L; Kahaly GJ; Baldeschi L; Dayan CM; Eckstein A; Marcocci C; Marinò M; Vaidya B; Wiersinga WM;
    Eur J Endocrinol; 2021 Aug; 185(4):G43-G67. PubMed ID: 34297684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimization of the treatment of moderate to severe and active thyroid orbitopathy considering the recommendations of the European Group on Graves' Orbitopathy (EUGOGO) [Optymalizacja leczenia umiarkowanej do ciężkiej i aktywnej orbitopatii tarczycowej z uwzględnieniem zaleceń European Group on Graves' Orbitopathy (EUGOGO)].
    Nowak M; Marek B; Kos-Kudła B; Siemińska L; Londzin-Olesik M; Głogowska-Szeląg J; Nowak W; Kajdaniuk D
    Endokrynol Pol; 2022; 73(4):756-777. PubMed ID: 36059167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Temporal trends in the clinical presentation of Graves' orbitopathy: a single-center retrospective study.
    Le Moli R; Naselli A; Giudice FL; Costanzo G; Frasca F; Belfiore A
    J Endocrinol Invest; 2024 Sep; 47(9):2177-2184. PubMed ID: 38488977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Graves' orbitopathy as a rare disease in Europe: a European Group on Graves' Orbitopathy (EUGOGO) position statement.
    Perros P; Hegedüs L; Bartalena L; Marcocci C; Kahaly GJ; Baldeschi L; Salvi M; Lazarus JH; Eckstein A; Pitz S; Boboridis K; Anagnostis P; Ayvaz G; Boschi A; Brix TH; Currò N; Konuk O; Marinò M; Mitchell AL; Stankovic B; Törüner FB; von Arx G; Zarković M; Wiersinga WM
    Orphanet J Rare Dis; 2017 Apr; 12(1):72. PubMed ID: 28427469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of Graves' ophthalmopathy in patients with Graves' disease presenting to a referral centre in north India.
    Reddy SV; Jain A; Yadav SB; Sharma K; Bhatia E
    Indian J Med Res; 2014 Jan; 139(1):99-104. PubMed ID: 24604044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical characteristics and the treatment modalities of Graves' orbitopathy in a tertiary referral center in Turkey: changes over two decades.
    Ozturk M; Konuk O; Tarlan B; Yalcın MM; Arıbas YK; Toruner FB; Unal M; Ayvaz G
    Int Ophthalmol; 2023 Feb; 43(2):643-653. PubMed ID: 36030455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and natural history of Graves' orbitopathy in a large series of patients with newly diagnosed graves' hyperthyroidism seen at a single center.
    Tanda ML; Piantanida E; Liparulo L; Veronesi G; Lai A; Sassi L; Pariani N; Gallo D; Azzolini C; Ferrario M; Bartalena L
    J Clin Endocrinol Metab; 2013 Apr; 98(4):1443-9. PubMed ID: 23408569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sight-threatening Graves' orbitopathy: Twenty years' experience of a multidisciplinary thyroid-eye outpatient clinic.
    Tramunt B; Imbert P; Grunenwald S; Boutault F; Caron P
    Clin Endocrinol (Oxf); 2019 Jan; 90(1):208-213. PubMed ID: 30339291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum selenium status in Graves' disease with and without orbitopathy: a case-control study.
    Khong JJ; Goldstein RF; Sanders KM; Schneider H; Pope J; Burdon KP; Craig JE; Ebeling PR
    Clin Endocrinol (Oxf); 2014 Jun; 80(6):905-10. PubMed ID: 24372054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of patients with Graves' orbitopathy: initial assessment, management outside specialised centres and referral pathways.
    Perros P; Dayan CM; Dickinson AJ; Ezra D; Estcourt S; Foley P; Hickey J; Lazarus JH; MacEwen CJ; McLaren J; Rose GE; Uddin J; Vaidya B
    Clin Med (Lond); 2015 Apr; 15(2):173-8. PubMed ID: 25824071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of biological sex, age and smoking on Graves' orbitopathy - a ten-year tertiary referral center analysis.
    Oeverhaus M; Winkler L; Stähr K; Daser A; Bechrakis N; Stöhr M; Chen Y; Eckstein A
    Front Endocrinol (Lausanne); 2023; 14():1160172. PubMed ID: 37082130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multi-center study on the characteristics and treatment strategies of patients with Graves' orbitopathy: the first European Group on Graves' Orbitopathy experience.
    Prummel MF; Bakker A; Wiersinga WM; Baldeschi L; Mourits MP; Kendall-Taylor P; Perros P; Neoh C; Dickinson AJ; Lazarus JH; Lane CM; Heufelder AE; Kahaly GJ; Pitz S; Orgiazzi J; Hullo A; Pinchera A; Marcocci C; Sartini MS; Rocchi R; Nardi M; Krassas GE; Halkias A
    Eur J Endocrinol; 2003 May; 148(5):491-5. PubMed ID: 12720530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive score for the development or progression of Graves' orbitopathy in patients with newly diagnosed Graves' hyperthyroidism.
    Wiersinga W; Žarković M; Bartalena L; Donati S; Perros P; Okosieme O; Morris D; Fichter N; Lareida J; von Arx G; Daumerie C; Burlacu MC; Kahaly G; Pitz S; Beleslin B; Ćirić J; Ayvaz G; Konuk O; Törüner FB; Salvi M; Covelli D; Curro N; Hegedüs L; Brix T;
    Eur J Endocrinol; 2018 Jun; 178(6):635-643. PubMed ID: 29650691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Management of Graves' orbitopathy: evidence-based recommendations].
    Ponto KA; Pitz S; Mann WJ; Weber MM; Pfeiffer N; Kahaly GJ
    Dtsch Med Wochenschr; 2009 Dec; 134(49):2521-4. PubMed ID: 19941237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Graves' orbitopathy].
    Eckstein A; Möller L; Führer D; Oeverhaus M
    Dtsch Med Wochenschr; 2021 Oct; 146(20):1344-1351. PubMed ID: 34644795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum selenium status in Egyptians patients who had Graves' disease with and without ophthalmopathy.
    Hasanin GA; Mohamed MS; Maher MM; Ahmed AM; ALi HM; Mansour HK
    Egypt J Immunol; 2024 Jan; 31(1):133-142. PubMed ID: 38224470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Consensus statement of the European Group on Graves' orbitopathy (EUGOGO) on management of GO.
    Bartalena L; Baldeschi L; Dickinson A; Eckstein A; Kendall-Taylor P; Marcocci C; Mourits M; Perros P; Boboridis K; Boschi A; Currò N; Daumerie C; Kahaly GJ; Krassas GE; Lane CM; Lazarus JH; Marinò M; Nardi M; Neoh C; Orgiazzi J; Pearce S; Pinchera A; Pitz S; Salvi M; Sivelli P; Stahl M; von Arx G; Wiersinga WM;
    Eur J Endocrinol; 2008 Mar; 158(3):273-85. PubMed ID: 18299459
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.